The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)7-8
Number of pages2
JournalBritish Journal of Haematology
Volume180
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Vidarabine
Hematologic Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Cyclophosphamide
Mutation
Survival
Rituximab
fludarabine

Keywords

  • chronic lymphocytic leukaemia
  • haematological malignancy
  • oncological intervention

ASJC Scopus subject areas

  • Hematology

Cite this

@article{405804ca1877433ca33724dacf3dab9e,
title = "The absolute percent deviation of IGHV mutation rather than a 98{\%} cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab",
keywords = "chronic lymphocytic leukaemia, haematological malignancy, oncological intervention",
author = "Christopher Gocke and Douglas Gladstone",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bjh.15015",
language = "English (US)",
volume = "180",
pages = "7--8",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

AU - Gocke, Christopher

AU - Gladstone, Douglas

PY - 2018/1/1

Y1 - 2018/1/1

KW - chronic lymphocytic leukaemia

KW - haematological malignancy

KW - oncological intervention

UR - http://www.scopus.com/inward/record.url?scp=85038233790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038233790&partnerID=8YFLogxK

U2 - 10.1111/bjh.15015

DO - 10.1111/bjh.15015

M3 - Editorial

C2 - 29205267

AN - SCOPUS:85038233790

VL - 180

SP - 7

EP - 8

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -